Page last updated: 2024-08-23

phenyl acetate and MODS

phenyl acetate has been researched along with MODS in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asahara, T; Hayakawa, K; Ikegawa, H; Kuwagata, Y; Matsushima, A; Nomoto, K; Ogura, H; Shimazu, T; Shimizu, K; Tasaki, O1
Atalay, F; Cadirci, E; Coskun, AK; Halici, Z; Mentes, O; Odabasoglu, F; Oral, A; Suleyman, H; Yigiter, M1
Abraham, E; Bandi, V; Dmitrienko, A; Farid, N; Forgue, ST; Gervich, D; Jiang, F; Lowry, SF; Macias, W; Naum, C; Schein, RM; Skerjanec, S; Wunderink, R1
Abraham, E; Dmitrienko, A; Fukiishi, Y; Laterre, PF; Steingrub, J; Zeiher, BG1
Ekşioğlu-Demiralp, E; Ercan, F; Gedik, N; Sakarcan, A; Sehirli, O; Sener, E; Sener, G; Yeğen, BC1
Hörl, WH; Riegel, W1

Reviews

1 review(s) available for phenyl acetate and MODS

ArticleYear
Cardiac depressant factors in renal disease.
    Circulation, 1993, Volume: 87, Issue:5 Suppl

    Topics: Acetates; Animals; Cardiomyopathies; Heart; Humans; Ions; Kidney Diseases; Kidney Failure, Chronic; Multiple Organ Failure; Myocardium; Parathyroid Hormone; Receptors, Adrenergic, beta; Renal Dialysis; Uremia

1993

Trials

2 trial(s) available for phenyl acetate and MODS

ArticleYear
Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure.
    Critical care medicine, 2003, Volume: 31, Issue:3

    Topics: Acetates; Aged; Cause of Death; Critical Illness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Group II Phospholipases A2; Hospital Mortality; Humans; Indoles; Inflammation; Infusions, Intravenous; Keto Acids; Male; Middle Aged; Molecular Weight; Multiple Organ Failure; Phospholipases A; Phospholipases A2; Proportional Hazards Models; Prospective Studies; Safety; Survival Analysis; Systemic Inflammatory Response Syndrome; Time Factors; Treatment Outcome; United States

2003
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis.
    Critical care medicine, 2005, Volume: 33, Issue:8

    Topics: Acetates; Double-Blind Method; Europe; Female; Group II Phospholipases A2; Humans; Indoles; Infusions, Intravenous; Keto Acids; Male; Middle Aged; Multiple Organ Failure; Phospholipases A; Phospholipases A2; Risk; Sepsis; United States

2005

Other Studies

3 other study(ies) available for phenyl acetate and MODS

ArticleYear
Gut microbiota and environment in patients with major burns – a preliminary report.
    Burns : journal of the International Society for Burn Injuries, 2015, Volume: 41, Issue:3

    Topics: Acetates; Adult; Aged; Bacteroidaceae; Bifidobacterium; Burns; Butyrates; Clostridium; Enterobacteriaceae; Enterococcus; Fatty Acids; Feces; Female; Gastrointestinal Microbiome; Humans; Lactobacillus; Male; Middle Aged; Multiple Organ Failure; Propionates; Pseudomonas; Staphylococcus; Systemic Inflammatory Response Syndrome

2015
The effects of montelukast on antioxidant enzymes and proinflammatory cytokines on the heart, liver, lungs, and kidneys in a rat model of cecal ligation and puncture-induced sepsis.
    TheScientificWorldJournal, 2011, Jul-07, Volume: 11

    Topics: Acetates; Animals; Cecum; Cyclopropanes; Cytokines; Disease Models, Animal; Glutathione; Heart; Kidney; Lipid Peroxides; Liver; Lung; Multiple Organ Failure; Myocardium; Peroxidase; Protective Agents; Quinolines; Rats; Reactive Oxygen Species; Sepsis; Sulfides; Superoxide Dismutase

2011
Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
    Prostaglandins & other lipid mediators, 2007, Volume: 83, Issue:4

    Topics: Acetates; Animals; Antioxidants; Apoptosis; Blood Urea Nitrogen; Collagen; Creatinine; Cyclopropanes; Glutathione; Interleukin-1beta; Interleukin-6; Kidney; Kidney Failure, Chronic; L-Lactate Dehydrogenase; Leukocytes; Leukotriene Antagonists; Lung; Male; Malondialdehyde; Membrane Proteins; Multiple Organ Failure; Quinolines; Random Allocation; Rats; Rats, Wistar; Receptors, Leukotriene; Sulfides; Tumor Necrosis Factor-alpha

2007